BR112012023836B1 - Compostos tricíclicos e composição farmacêutica compreendendo os referidos compostos - Google Patents
Compostos tricíclicos e composição farmacêutica compreendendo os referidos compostos Download PDFInfo
- Publication number
- BR112012023836B1 BR112012023836B1 BR112012023836-1A BR112012023836A BR112012023836B1 BR 112012023836 B1 BR112012023836 B1 BR 112012023836B1 BR 112012023836 A BR112012023836 A BR 112012023836A BR 112012023836 B1 BR112012023836 B1 BR 112012023836B1
- Authority
- BR
- Brazil
- Prior art keywords
- quinolin
- phenyl
- hydroxy
- hydroxythieno
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31860610P | 2010-03-29 | 2010-03-29 | |
| US61/318,606 | 2010-03-29 | ||
| PCT/US2011/030278 WO2011123419A1 (en) | 2010-03-29 | 2011-03-29 | Trycyclic compounds and pbk inhibitors containing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112012023836A2 BR112012023836A2 (pt) | 2015-09-22 |
| BR112012023836B1 true BR112012023836B1 (pt) | 2022-02-01 |
Family
ID=44712585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012023836-1A BR112012023836B1 (pt) | 2010-03-29 | 2011-03-29 | Compostos tricíclicos e composição farmacêutica compreendendo os referidos compostos |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8962648B2 (https=) |
| EP (1) | EP2552206B1 (https=) |
| JP (1) | JP5849302B2 (https=) |
| KR (1) | KR101757502B1 (https=) |
| CN (1) | CN102917590B (https=) |
| AU (1) | AU2011235319B2 (https=) |
| BR (1) | BR112012023836B1 (https=) |
| CA (1) | CA2792941C (https=) |
| DK (1) | DK2552206T3 (https=) |
| ES (1) | ES2547571T3 (https=) |
| IL (1) | IL222080B (https=) |
| MX (1) | MX2012011412A (https=) |
| SG (1) | SG184376A1 (https=) |
| TW (1) | TWI503323B (https=) |
| WO (1) | WO2011123419A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2857848T3 (es) * | 2013-12-24 | 2021-09-29 | Bristol Myers Squibb Co | Compuestos tricíclicos como agentes antineoplásicos |
| TWI557011B (zh) | 2015-05-25 | 2016-11-11 | 可影像處理的自行車錶裝置 | |
| KR20180011843A (ko) | 2015-06-11 | 2018-02-02 | 바실리어 파마슈티카 인터내셔널 리미티드 | 유출-펌프 억제제 및 이의 치료적 용도 |
| GB201617758D0 (en) | 2016-10-20 | 2016-12-07 | Almac Discovery Limited | Pharmaceutical compounds |
| CN108341774B (zh) * | 2017-01-25 | 2022-07-19 | 首药控股(北京)股份有限公司 | 取代的喹啉酮类抑制剂 |
| EP3609869A1 (de) | 2017-04-10 | 2020-02-19 | Bayer Aktiengesellschaft | Substituierte n-arylethyl-2-arylchinolin-4-carboxamide und ihre verwendung |
| WO2019094404A1 (en) * | 2017-11-07 | 2019-05-16 | Temple University-Of The Commonwealth System Of Higher Education | Compositions and methods for improved t cells |
| CN111099941B (zh) * | 2018-10-26 | 2022-10-18 | 中国科学院上海有机化学研究所 | 一种烷基腈类化合物的制备方法 |
| TW202300150A (zh) * | 2021-03-18 | 2023-01-01 | 美商薛定諤公司 | 環狀化合物及其使用方法 |
| CN117120447A (zh) * | 2021-03-18 | 2023-11-24 | 薛定谔公司 | 环状化合物和其使用方法 |
| WO2024008113A1 (zh) * | 2022-07-07 | 2024-01-11 | 深圳微芯生物科技股份有限公司 | 一种甲酰胺取代的杂三环类衍生物、其制备方法及其应用 |
| WO2024097228A1 (en) * | 2022-10-31 | 2024-05-10 | Meliora Therapeutics, Inc. | Compounds targeting cdk11 and methods of using the same |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5377096A (en) * | 1976-12-17 | 1978-07-08 | Teijin Ltd | Preparation of thieno 2,3-c quinolin-4(5h)-one-7-acetic acids |
| FR2636063B1 (fr) * | 1988-09-05 | 1993-04-30 | Centre Nat Rech Scient | Composes phenylpyrroliques utiles en tant que medicaments, leur preparation et leur application |
| DE19806348A1 (de) * | 1998-02-12 | 1999-08-19 | Schering Ag | 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln |
| US6506769B2 (en) * | 1999-10-06 | 2003-01-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| US6638929B2 (en) | 1999-12-29 | 2003-10-28 | Wyeth | Tricyclic protein kinase inhibitors |
| CA2396579A1 (en) * | 1999-12-29 | 2001-07-05 | Wyeth | Tricyclic protein kinase inhibitors |
| DE10242106A1 (de) | 2002-09-11 | 2004-04-15 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Phosphorgruppenhaltige Carbonsäurederivate mit organisch polymerisierbaren Gruppen |
| HRP20050248A2 (en) | 2002-09-17 | 2005-10-31 | Warner-Lambert Company Llc | Heterocyclic substituted piperazines for the treatment of schizophrenia |
| US20040157804A1 (en) | 2002-10-16 | 2004-08-12 | Gilead Sciences, Inc. | Pre-organized tricyclic integrase inhibitor compounds |
| GB0501999D0 (en) * | 2005-02-01 | 2005-03-09 | Sentinel Oncology Ltd | Pharmaceutical compounds |
| US7956064B2 (en) * | 2006-09-01 | 2011-06-07 | Cylene Pharmaceuticals, Inc. | Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators |
| AU2008277377B2 (en) | 2007-07-19 | 2013-08-01 | Msd Italia S.R.L. | Macrocyclic compounds as antiviral agents |
| AU2009219154A1 (en) * | 2008-02-29 | 2009-09-03 | Cylene Pharmaceuticals, Inc. | Protein kinase modulators |
-
2011
- 2011-03-28 TW TW100110555A patent/TWI503323B/zh not_active IP Right Cessation
- 2011-03-29 WO PCT/US2011/030278 patent/WO2011123419A1/en not_active Ceased
- 2011-03-29 JP JP2013502740A patent/JP5849302B2/ja active Active
- 2011-03-29 CN CN201180026805.8A patent/CN102917590B/zh active Active
- 2011-03-29 EP EP11763307.3A patent/EP2552206B1/en active Active
- 2011-03-29 MX MX2012011412A patent/MX2012011412A/es active IP Right Grant
- 2011-03-29 CA CA2792941A patent/CA2792941C/en active Active
- 2011-03-29 AU AU2011235319A patent/AU2011235319B2/en not_active Ceased
- 2011-03-29 KR KR1020127027125A patent/KR101757502B1/ko not_active Expired - Fee Related
- 2011-03-29 US US13/202,544 patent/US8962648B2/en active Active
- 2011-03-29 SG SG2012072807A patent/SG184376A1/en unknown
- 2011-03-29 ES ES11763307.3T patent/ES2547571T3/es active Active
- 2011-03-29 BR BR112012023836-1A patent/BR112012023836B1/pt not_active IP Right Cessation
- 2011-03-29 DK DK11763307.3T patent/DK2552206T3/en active
-
2012
- 2012-09-23 IL IL222080A patent/IL222080B/en active IP Right Grant
-
2014
- 2014-12-09 US US14/565,047 patent/US9453025B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102917590A (zh) | 2013-02-06 |
| SG184376A1 (en) | 2012-11-29 |
| EP2552206A1 (en) | 2013-02-06 |
| RU2012145855A (ru) | 2014-05-10 |
| HK1179114A1 (en) | 2013-09-27 |
| CN102917590B (zh) | 2016-02-17 |
| EP2552206A4 (en) | 2013-08-14 |
| CA2792941C (en) | 2017-09-12 |
| US9453025B2 (en) | 2016-09-27 |
| IL222080B (en) | 2018-05-31 |
| WO2011123419A1 (en) | 2011-10-06 |
| BR112012023836A2 (pt) | 2015-09-22 |
| DK2552206T3 (en) | 2015-09-28 |
| AU2011235319A1 (en) | 2012-10-11 |
| KR20130020666A (ko) | 2013-02-27 |
| US20130178459A1 (en) | 2013-07-11 |
| MX2012011412A (es) | 2013-02-07 |
| US8962648B2 (en) | 2015-02-24 |
| TWI503323B (zh) | 2015-10-11 |
| JP5849302B2 (ja) | 2016-01-27 |
| ES2547571T3 (es) | 2015-10-07 |
| JP2013523749A (ja) | 2013-06-17 |
| CA2792941A1 (en) | 2011-10-06 |
| KR101757502B1 (ko) | 2017-07-12 |
| AU2011235319B2 (en) | 2016-07-14 |
| EP2552206B1 (en) | 2015-07-22 |
| US20150183799A1 (en) | 2015-07-02 |
| TW201136939A (en) | 2011-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012023836B1 (pt) | Compostos tricíclicos e composição farmacêutica compreendendo os referidos compostos | |
| AU2019201352B2 (en) | Bromodomain inhibitors | |
| CN105377851B (zh) | Bet布罗莫结构域抑制剂和使用这些抑制剂的治疗方法 | |
| CN102471341B (zh) | 治疗寄生虫疾病如疟疾的稠合咪唑化合物和含有它们的组合物 | |
| CN104768932B (zh) | Pde4的杂芳基抑制剂 | |
| CN104053661B (zh) | 非典型性蛋白激酶c的噻吩并嘧啶类抑制剂 | |
| CN107074787A (zh) | 赖氨酸特异性脱甲基酶‑1的抑制剂 | |
| CA2990089A1 (en) | New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| CA2933480A1 (en) | Inhibitors of lysine specific demethylase-1 | |
| TWI736619B (zh) | 用於治療疼痛及相關狀況的新四氫嘧啶並二吖呯及二氫吡啶並二吖呯化合物 | |
| CA2772989A1 (en) | Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer | |
| AU2018341781B2 (en) | Fused ring derivative as A2A receptor inhibitor | |
| TW202241413A (zh) | 吡唑並喹唑啉類化合物、其製備方法及用途 | |
| WO2024249817A1 (en) | Tricyclic pkmyt1 kinase inhibitors | |
| RU2574398C2 (ru) | ПРОИЗВОДНЫЕ ТИЕНО[2,3-с]ХИНОЛИНА-4-ОНА, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ РВК-ЗАВИСИМОГО ЗАБОЛЕВАНИЯ | |
| HK1179114B (en) | Tricyclic compounds and pbk inhibitors containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A01N 43/42 , C07D 221/06 Ipc: C07D 221/06 (2006.01), A61P 35/00 (2006.01), C07D |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/03/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 14A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2822 DE 04-02-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |